» Articles » PMID: 35223156

Prevalence of Atherosclerosis in Psoriatic Patients Detected with Epiaortic Color Doppler Ultrasound and Computed Tomography Angiography

Abstract

Introduction: Psoriasis (PsO), a chronic inflammatory, multisystemic, and multifactorial disease can cause endothelial dysfunction, artery calcification, and atherosclerotic disease. A higher incidence of vascular occlusive events has been observed in psoriatic patients compared to healthy controls, and multiple studies confirm the association between moderate-severe PsO and atherosclerosis, coronary artery calcification, and higher cardiovascular risk.

Objective: We sought to analyze atherosclerotic disease prevalence in epiaortic vessels of psoriatic and non-psoriatic patients to understand if PsO could represent an independent risk factor predisposing to atherosclerotic disease.

Methods: We evaluated 47 psoriatic patients without cardiovascular risk factors with color Doppler ultrasound (CDUS). If atheromatous plaques were detected, a computed tomography angiography (CTA) was performed. We evaluated 47 non-psoriatic patients without cardiovascular risk factors with CDUS. Atherosclerosis prevalence in both groups were statistically analyzed. CDUS performance was compared to CTA.

Results: In the psoriatic group (mean age 50.9 years), 6 had atheromatous plaques and 12 had an intima-media thickness (IMT) > 1 mm (overall prevalence of atherosclerotic disease: 38.2%). All plaques detected with CDUS were confirmed at CTA. In the control group (mean age 51.3 years), CDUS revealed atheromatous plaques in 4 patients and IMT > 1 mm in 4 ones (overall prevalence of 17%). The difference of atherosclerotic disease prevalence between the groups was statistically significant (P < 0.05).

Conclusion: Our results highlight that PsO could be considered a predisposing factor for atherosclerotic disease development in epiaortic vessels, as it causes an increased IMT, that is also considered an independent cardiovascular risk factor.

Citing Articles

Impact of topical and systemic therapy on carotid-intima media thickness in psoriasis.

Gumus E, Celik U, Gumus S, Engin B Arch Dermatol Res. 2025; 317(1):286.

PMID: 39825924 DOI: 10.1007/s00403-025-03818-7.


Blunted Microvascular Reactivity in Psoriasis Patients in the Absence of Cardiovascular Disease, as Assessed by Laser Speckle Contrast Imaging.

Margouta A, Anyfanti P, Lazaridis A, Nikolaidou B, Mastrogiannis K, Malliora A Life (Basel). 2022; 12(11).

PMID: 36362951 PMC: 9693319. DOI: 10.3390/life12111796.

References
1.
Brauchli Y, Jick S, Miret M, Meier C . Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009; 160(5):1048-56. DOI: 10.1111/j.1365-2133.2008.09020.x. View

2.
Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A . Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004; 19(3):225-30. DOI: 10.1023/b:ejep.0000020447.59150.f9. View

3.
Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A . Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007; 157(1):68-73. DOI: 10.1111/j.1365-2133.2007.07986.x. View

4.
Zeb I, Budoff M . Coronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools?. Int J Mol Sci. 2015; 16(3):6606-20. PMC: 4394551. DOI: 10.3390/ijms16036606. View

5.
Johri A, Nambi V, Naqvi T, Feinstein S, Kim E, Park M . Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020; 33(8):917-933. DOI: 10.1016/j.echo.2020.04.021. View